These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 27683128)

  • 1. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
    Chistiakov DA; Chekhonin VP
    Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
    Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
    Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional studies on circulating and disseminated tumor cells in carcinoma patients.
    Alix-Panabières C; Bartkowiak K; Pantel K
    Mol Oncol; 2016 Mar; 10(3):443-9. PubMed ID: 26847851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges in metastasis: disseminated and circulating tumor cells detection.
    Shahneh FZ
    Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.
    Liu X; Li J; Cadilha BL; Markota A; Voigt C; Huang Z; Lin PP; Wang DD; Dai J; Kranz G; Krandick A; Libl D; Zitzelsberger H; Zagorski I; Braselmann H; Pan M; Zhu S; Huang Y; Niedermeyer S; Reichel CA; Uhl B; Briukhovetska D; Suárez J; Kobold S; Gires O; Wang H
    Sci Adv; 2019 Jun; 5(6):eaav4275. PubMed ID: 31223646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
    Mirza S; Jain N; Rawal R
    Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
    Joosse SA; Pantel K
    Cancer Metastasis Rev; 2016 Mar; 35(1):41-8. PubMed ID: 26931653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
    Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.
    Hong Y; Zhang Q
    Tumour Biol; 2016 May; 37(5):5663-74. PubMed ID: 26758432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
    Kölbl AC; Jeschke U; Andergassen U
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of circulating tumor cells in metastatic breast cancer.
    Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
    Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
    Steinert G; Schölch S; Koch M; Weitz J
    Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
    Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
    J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells in breast cancer--current status and perspectives.
    Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
    Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal plasticity in circulating tumor cells.
    Alix-Panabières C; Mader S; Pantel K
    J Mol Med (Berl); 2017 Feb; 95(2):133-142. PubMed ID: 28013389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.